ISSN 2816-7988
Vol. 33, Issue 1, 2022April 15, 2022 EDT
Optical Coherence Tomography Features Predicting the Response of Diabetic Macular Oedema to Treatment with Fluocinolne Acetonide Intravitreal Implant, a Cohort Study.
Optical Coherence Tomography Features Predicting the Response of Diabetic Macular Oedema to Treatment with Fluocinolne Acetonide Intravitreal Implant, a Cohort Study.
Articles in Vol. 33, Issue 1, 2022
Vol. 33, Issue 1, 2022
- Laser Pointer Retinopathy: A Case Report and ReviewPriya SwatchAnnie ChangRaman Bhakhri
- Case Series: Paracentral Acute Middle Maculopathy as a Sign of Severe Systemic VasculopathyLorraine ChengXiao X. Yu
- Optical Coherence Tomography Features Predicting the Response of Diabetic Macular Oedema to Treatment with Fluocinolne Acetonide Intravitreal Implant, a Cohort Study.Hani HasamAdam HatoumYoussef HelmyDaniel HornanEvangelos Minos
- Acquired Vitelliform Lesions in the Setting of Nonexudative Age-Related Macular DegenerationEni NanoFatima RaposoPaul B. GreenbergBrian Savoie
1.
Hasam H, Hatoum A, Helmy Y, Hornan D, Minos E. Optical Coherence Tomography Features Predicting the Response of Diabetic Macular Oedema to Treatment with Fluocinolne Acetonide Intravitreal Implant, a Cohort Study. CRO Journal. 2022;33(1). doi:10.57204/001c.36530